GPER1 and breast carcinoma: Considering that assessment of the GPER expression holds potential as a prognostic tool, as a biomarker, and as a therapeutic target in certain cancer types (e.g., ovarian and breast cancer), a strong effort has been pursued towards the development of novel nuclear molecular probes for non-invasive targeting/imaging of that receptor in vivo.